OB/GYN Clinical Alert – March 1, 2004
March 1, 2004
View Issues
-
Determining Menopause in Women Using Depo-Provera
Beksinska and colleagues from South Africa measured FSH levels in long-term older users of depot-medroxyprogesterone acetate (117 women) and norethindrone enanthate (60 women), long-acting progestin-only methods of contraception. -
Myometrial Invasion and the Tumor-Free Distance from the Uterine Serosa in Endometrial Cancer?
Lindauer and colleagues set out to evaluate whether the tumor-free distance from the uterine serosa to the deepest invasive lesion was a better predictor of patient outcome from endometrial cancer than the traditional measure of myometrial invasion. To do this, they retrospectively evaluated all surgically staged endometrial adenocarcinoma patients between 1997 and 2000. -
Enthusiasm for Cancer Screening in the United States
Most Americans believe that screening tests for cancer save lives and that it is irresponsible not to undergo recommended periodic screening. The presence of a large market for cancer screening may make Americans vulnerable to unproven and unnecessary testing. -
Results of Interval Debulking Surgery Compared with Primary Debulking Surgery in Advanced- Stage Ovarian Cancer
Survival rates were similar in patients with advanced-stage ovarian cancer who underwent IDS or PDS. The rates of surgical resection and morbidity were reduced after IDS. IDS can be safely used in unresectable advanced-stage ovarian cancer. -
Special Feature: Quick Hits
False-Positive One-Hour Glucose Screens are Associated with Higher Rates of Perinatal Complications than Negative Screens; Dont be Mislead by the Short Take; More Information Regarding Single vs Double Layer Closure of the Uterus During Cesarean Section -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Sinus and Allergy Health Partnership Releases New Guidelines for Treatment of Bacterial Rhinosinusitis
Sinus and Allergy Health Partnership Releases New Guidelines for Treatment of Bacterial Rhinosinusitis; Steroids Not Linked to Risk of Fractures; ADT Puts Men at Risk for Osteoporosis; Study Shows Valsartan May Improve Sexual Function in Postmenopausal Women; New Direct-to-Consumer Pharma Advertising Rules Considered